Core Concept - The article discusses the transformative potential of AI for Science (AI4S) in reshaping China's technological landscape, emphasizing its role in enhancing foundational research efficiency and addressing critical industry challenges [3][9][10]. Group 1: AI4S Overview - AI4S represents a paradigm shift in scientific research, moving from a trial-and-error approach to a data and model-driven methodology, which is crucial for overcoming efficiency bottlenecks in foundational research [3][4]. - The integration of AI into foundational research is seen as a key factor for China's technological breakthroughs, particularly in critical sectors such as new materials, biomedicine, and semiconductors [3][9]. Group 2: Applications in New Materials - Fangda Carbon (600516.SH) and Jingtai Technology's collaboration exemplifies the application of AI4S in new materials, significantly reducing the research and development cycle from 2-3 years to 3-6 months [5]. - The partnership aims to optimize production processes and improve product yield by over 15%, showcasing the practical benefits of AI integration in traditional manufacturing [5]. Group 3: Applications in Biomedicine - Medicy (688202.SH) has redefined the drug development process through AI, achieving a significant reduction in the clinical research cycle by 40% and enhancing the accuracy of toxicity predictions to 92% [6][7]. - The company’s AI-driven platform integrates advanced technologies like Google’s AlphaFold3 and NVIDIA’s BioNeMo, allowing for rapid iteration in drug discovery and positioning China at the forefront of global pharmaceutical research [6][7]. Group 4: Applications in Semiconductors - DaoTech (300409.SZ) addresses the computational challenges in AI4S by developing specialized chips for atomic-level scientific calculations, which are essential for both materials and chip research [8]. - The establishment of the Hexi Atomic Computing Center enables a synergistic relationship between chip development and materials design, enhancing the efficiency of both fields [8]. Group 5: Market Dynamics and Future Outlook - The success of AI4S in China is attributed to a combination of industry demand, technological innovation, and supportive government policies, which collectively foster a conducive environment for AI integration in foundational research [9]. - Despite challenges such as data scarcity and talent shortages, AI4S presents unprecedented opportunities for China to advance in foundational research areas, potentially leading to a shift from a follower to a leader in global technology innovation [9][10].

Core Insights - DaoTech announced that its investee company, Chipenson, is progressing as planned with the development of its second-generation APU products, expected to enter the tape-out phase by the end of this year or early next year [3] - The APU products from Chipenson demonstrate a computational speed improvement of 1-3 orders of magnitude and a power consumption reduction of 2-3 orders of magnitude compared to traditional CPU/GPU systems, with no direct competitors in the non-Von Neumann architecture domain for atomic scientific computing acceleration [3] - The HeXi Atomic Computing Center, a joint venture between DaoTech and Chipenson, aims to be the world's first large-scale computing center focused on atomic-level scientific calculations, with a registered capital of 50 million yuan, where DaoTech holds an 80% stake [4] Company Developments - DaoTech is actively involved in the preliminary government approval, engineering design, equipment selection, and infrastructure setup for the HeXi Atomic Computing Center, with plans to establish 200 units by the end of this year and a total of 1,000 units in the future [3][4] - The center is positioned to support enterprises in their digital transformation by providing robust computing power, leveraging DaoTech's material research data and industry experience alongside Chipenson's APU chip and server technology [4]